tiprankstipranks
Trending News
More News >
Tianda Pharmaceuticals Ltd. (HK:0455)
:0455
Hong Kong Market

Tianda Pharmaceuticals Ltd. (0455) Financial Statements

Compare
0 Followers

Tianda Pharmaceuticals Ltd. Financial Overview

Tianda Pharmaceuticals Ltd.'s market cap is currently HK$268.76M. The company's EPS TTM is HK$-0.016; its P/E ratio is -3.99; Tianda Pharmaceuticals Ltd. is scheduled to report earnings on August 28, 2025, and the estimated EPS forecast is HK$―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total RevenueHK$ 329.94MHK$ 532.09MHK$ 546.69MHK$ 509.96MHK$ 474.33M
Gross ProfitHK$ 152.02MHK$ 255.53MHK$ 251.52MHK$ 241.22MHK$ 258.99M
Operating IncomeHK$ -54.15MHK$ -29.02MHK$ -70.14MHK$ -38.97MHK$ -26.76M
EBITDAHK$ -49.49MHK$ 15.66MHK$ -19.89MHK$ -5.14MHK$ -6.25M
Net IncomeHK$ -61.37MHK$ -24.16MHK$ -54.64MHK$ -21.67MHK$ -25.92M
Balance Sheet
Cash & Short-Term InvestmentsHK$ 85.69MHK$ 162.44MHK$ 343.44MHK$ 334.00MHK$ 234.98M
Total AssetsHK$ 765.02MHK$ 917.29MHK$ 1.09BHK$ 1.16BHK$ 1.13B
Total DebtHK$ 127.44MHK$ 113.60MHK$ 141.05MHK$ 160.43MHK$ 145.53M
Net DebtHK$ 41.76MHK$ -48.84MHK$ -199.23MHK$ -173.57MHK$ -89.45M
Total LiabilitiesHK$ 259.36MHK$ 325.35MHK$ 434.23MHK$ 375.08MHK$ 342.97M
Stockholders' EquityHK$ 505.84MHK$ 592.07MHK$ 627.83MHK$ 756.75MHK$ 756.71M
Cash Flow
Free Cash FlowHK$ -52.30MHK$ -116.04MHK$ 54.73MHK$ -61.98MHK$ -184.08M
Operating Cash FlowHK$ -9.70MHK$ -49.76MHK$ 79.11MHK$ -8.23MHK$ -37.63M
Investing Cash FlowHK$ -31.77MHK$ -69.10MHK$ -12.20MHK$ 86.35MHK$ -137.73M
Financing Cash FlowHK$ -30.65MHK$ -57.39MHK$ -28.98MHK$ -1.29MHK$ 90.75M
Currency in HKD

Tianda Pharmaceuticals Ltd. Earnings and Revenue History

Tianda Pharmaceuticals Ltd. Debt to Assets

Tianda Pharmaceuticals Ltd. Cash Flow

Tianda Pharmaceuticals Ltd. Forecast EPS vs Actual EPS